相关实验视频

Updated: Jun 13, 2025

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

了解α-阿米尼丁肝毒性:来自细胞模型的机制

Haowei Wang¹, Xiaoxing Zhang¹, Xiaodong Li¹

¹Department of Forensic Medicine, School of Forensic Medicine, Kunming Medical University, Kunming, China.

|June 4, 2025

概括

阿尔法-阿曼尼丁 (α-AMA) 是一种有毒的化合物,通过多个细胞通路引起肝损伤. 了解这些机制是开发更好的α-AMA中毒治疗方法的关键.

科学领域:

毒理学毒理学毒理学
肝病学肝病学是一种肝病学.
细胞生物学细胞生物学

背景情况:

阿尔法-阿曼尼丁 (α-AMA) 是一种在中发现的致命毒素,可引起严重的中毒.
肝毒性是α-AMA中毒的主要后果,由复杂和多方面的细胞机制驱动.

研究的目的:

综合当前关于α-AMA诱导的肝毒性知识,重点关注最近的细胞模型发现.
阐明通过α-AMA损害肝细胞的复杂细胞通路.

主要方法:

对α-AMA毒性现有文献的综述.
分析最近使用细胞模型研究α-AMA对肝细胞的影响的研究.

主要成果:

α-AMA通过RNA聚合酶II抑制,氧化应激,亡,自,炎症和免疫毒性诱导肝毒性.
新出现的证据表明,在α-AMA介导的肝损伤中,细胞内膜网膜应激和N-糖基化途径是相关的.

结论:

目前用于α-AMA中毒的排毒剂的疗效低于最佳.
对α-AMA细胞机制的进一步研究对于开发改进的治疗策略至关重要.
高通量查和基因编辑技术可以确定α-AMA毒性的新疗法标.

关键词:

细胞模型的细胞模型.肝毒性机制肝毒性机制 α-阿曼尼提尼尼是什么?

更多相关视频

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

相关概念视频

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...